SPIN Flashcards
SPIN
What is the name of the trial
SPIN (Scottish Pregnancy Intervention) study: a multicentre randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage
SPIN
Authors
Where was it published
Clark, walker, Langhorne et al
Blood 2010
SPIN
Where when
NZ and UK 2004 - 2008 Multicentre RCT (not blind)
SPIN
Outcomes
Loss of the index pregnancy
Secondary - complications of tx
SPIN
Method
294 randomized (147 each arm) to anticoagulation or monitoring
Randomisation by telephone - randomized envelopes
Both groups 2 weekly USS until 12 weeks then monthly until 28 weeks
FBC in treatment arm 7 days 28/40 36/40
Both groups had thrombophilia testing at booking at at 12 weeks
SPIN
intervention
75 mg aspirin and 40 mg LMWH and close monitoring vs close monitoring
SPIN population
Inclusion and exclusions
Most recent consecutive 2 pregnancies were lost <24 weeks Presentation for AN care <7 weeks with positive pregnancy test
Exclusions
Previous investigations that had determined that the fetal loss was due to another cause
anatomic, chromosomal, endocrine, immunologic cause
Previous VTE
Known APS or thrombophilia or new Dx APS
Condition that needed Tx Anaemia requiring transfusion Platelets <150
Abnormal TFTs
SPIN
hypothesis
To assess if aspirin and LMWH + intensive pregnancy surveillance vs intensive surveillance alone reduces rate of pregnancy loss
SPIN Results
22% pregnancy loss in intervention group vs 20% in control group - no statistical significance
Therefore no benefit in giving aspirin and clexane for recurrent pregnancy loss
no complications of tx
SPIN strengths and weaknesses
Not able to do subgroup analysis
Not blinded
50% had 2 or more losses - ? if it would help 3 or more losses
Strength RCT Adequately powered
SPIN Discussion
Study may not be applicable to those with >/=3 recurrent pregnancy losses. Outcomes seem the same in treatment and control groups in this subgroup analysis however
Overall successful pregnancy rates of 79.2% the same as reported 80%
Further studies on the use of LMWH and aspirin at the time of implantation for those with recurrent pregnancy loss and inherited thrombophilia